Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shmulewitz

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Genetic Epidemiology|January 17, 2002
Genome scans for Q1 and Q2 on general population replicates using LokiD Shmulewitz, S C Heath
Psychological Medicine|May 4, 2022
Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids)D Shmulewitz, M Stohl, E Greenstein, et al.
Psychological Medicine|January 15, 2013
Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokersD Shmulewitz, M M Wall, E Aharonovich, et al.
Addictive Behaviors|January 15, 2021
Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approachC Kervran, D Shmulewitz, F Serre, et al.
Human Heredity|November 30, 2000
Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of MicronesiaD Shmulewitz, S B Auerbach, T Lehner, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Genetic Epidemiology|January 17, 2002
Genome scans for Q1 and Q2 on general population replicates using LokiD Shmulewitz, S C Heath
Psychological Medicine|May 4, 2022
Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids)D Shmulewitz, M Stohl, E Greenstein, et al.
Psychological Medicine|January 15, 2013
Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokersD Shmulewitz, M M Wall, E Aharonovich, et al.
Addictive Behaviors|January 15, 2021
Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approachC Kervran, D Shmulewitz, F Serre, et al.
Human Heredity|November 30, 2000
Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of MicronesiaD Shmulewitz, S B Auerbach, T Lehner, et al.
Pageof 1